Stocks
iShares Biotechnology ETFIBB
NASDAQHealthcareBiotechnology$165.51-0.43%
An exchange-traded fund that provides exposure to U.S. biotechnology companies, offering investors diversified access to firms engaged in drug development, medical devices, and genetic research. It is widely tracked as a benchmark for the biotech sector due to its broad market coverage and liquidity.
Market Cap: $8.0B52W Range: $107.43 – $179.64
Congressional Interest in iShares Biotechnology ETF (IBB)
9 members of Congress have disclosed 12 trades in iShares Biotechnology ETF (IBB), a Healthcare company. The buy/sell breakdown shows 4 purchases versus 8 sales, indicating net selling pressure from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
12
Unique Politicians
9
Buys
4
Sells
8
Who in Congress Is Trading IBB?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2017-02-23 | DAVID P. JOYCE | sell | $1K – $15K |
| 2017-02-17 | DAVID P. JOYCE | sell | $1K – $15K |